...

Lyrica 300 mg (Generic)

Medically reviewed by Sanjay Gangani, B.Pharm, CMO & Pharmacist

Active Ingredient Pregabalin
Indication muscle pain
Manufacturer HAB Pharmaceuticals & Research Ltd
Strength:- 300mg
Packaging 15 capsules in 1 strip

Lyrica 300 mg (Generic)

Pack Size Price Price/unit Quantity Add To Cart
90 Capsule/s $115 $1.28/Piece
180 Capsule/s $220 $1.22/Piece
300 Capsule/s $300 $1.00/Piece

WHAT IS LYRICA 300 MG

  • Lyrica is the original brand of pregabalin.

  • Each 300 mg hard capsule contains 300 mg of pregabalin.

  • Pregabalin is a prescription medicine for nerve pain and seizures.

  • It belongs to a group called gabapentinoids.

  • It is not an ordinary painkiller or anti-inflammatory.

  • Lyrica 75 mg treats pain caused by damaged or irritated nerves.

  • In Europe it covers peripheral and central neuropathic pain.

  • Peripheral means nerve pain in the limbs, as in diabetes.

  • Central means nerve pain from the brain or spinal cord.

  • It is also used as add-on treatment for partial seizures.

  • In Europe it is also approved for generalised anxiety disorder.

  • Each capsule contains Lyrica 150 mg of lactose.

  • It can cause dependence, even at normal doses.

HOW IT WORKS (MECHANISM OF ACTION)

Step by step

  • Damaged nerves become overexcitable and fire too easily.

  • Nerve endings release signalling chemicals when calcium enters.

  • Pregabalin binds the alpha-2-delta subunit of calcium channels.

  • That subunit is an auxiliary part of the calcium channel.

  • Binding reduces calcium entry into the nerve ending.

  • Less calcium means less release of excitatory chemicals.

  • Those chemicals include glutamate, noradrenaline and substance P.

  • Nerve signalling therefore settles down.

  • Fewer pain signals reach the brain.

  • In epilepsy, the same effect limits seizure spread.

  • In anxiety, it reduces excitatory signalling in brain circuits.

Two facts that drive every dosing rule

  • Pregabalin is barely metabolised by the liver.

  • It has negligible plasma protein binding.

  • So pharmacokinetic drug interactions are unlikely.

  • It is cleared almost entirely by the kidneys, unchanged.

  • So the dose must be cut when kidney function falls.

  • No dose change is needed in liver impairment.

  • It is not an opioid and does not act on opioid receptors.

  • It is not a benzodiazepine, although it can sedate like one.

  • It does not bind GABA receptors, despite the similar name.

  • It does not reduce inflammation.

  • It will not help ordinary muscle or joint pain.

DOSAGE GUIDE

Titration schedules, European SmPC

IndicationStartThenThenMaximum
Neuropathic pain150 mg/day300 mg/day after 3 to 7 days600 mg/day after a further 7 days600 mg/day
Epilepsy, add-on150 mg/day300 mg/day after 1 week600 mg/day after a further week600 mg/day
Generalised anxiety disorder150 mg/day300 mg/day after 1 week450 mg/day after another week, then 600 mg/day after a further week600 mg/day
  • Every daily dose is divided into two or three doses.

  • A 300 mg capsule twice daily gives the 600 mg maximum.

  • Reaching that maximum takes at least two weeks of titration.

  • Nobody should start treatment on a 300 mg capsule.

  • In anxiety, the need for treatment should be reassessed regularly.

US FDA caps, which differ

IndicationStarting doseMaximum
Diabetic peripheral neuropathy pain50 mg three times daily300 mg/day
Pain after shingles75 mg twice daily or 50 mg three times daily600 mg/day
Nerve pain after spinal cord injury75 mg twice daily600 mg/day
Fibromyalgia75 mg twice daily450 mg/day
Add-on for partial-onset seizures, adults150 mg/day600 mg/day
  • For diabetic nerve pain the US cap is 300 mg a day.

  • That is given as 100 mg three times daily.

  • A 300 mg capsule does not fit that regimen.

  • For fibromyalgia the US cap is 450 mg a day.

  • 300 mg twice daily would exceed that cap.

Kidney function, European SmPC table

Creatinine clearanceStarting doseMaximum doseRegimen
60 mL/min or more150 mg/day600 mg/dayTwo or three doses
30 to under 60 mL/min75 mg/day300 mg/dayTwo or three doses
15 to under 30 mL/min25 to 50 mg/day150 mg/dayOnce or twice daily
Under 15 mL/min25 mg/day75 mg/dayOnce daily
Haemodialysis supplement25 mg100 mgOne extra dose after each 4-hour session
  • Older patients often need a lower dose for this reason.

  • Kidney function should be checked before the dose is set.

Stopping the medicine

Current daily doseMinimum taper period
150 to 300 mg a dayAt least 1 week
600 mg a dayAt least 3 weeks
  • Never stop pregabalin suddenly.

  • Abrupt stopping can cause convulsions.

  • It can also cause insomnia, headache, nausea and anxiety.

  • It can also cause diarrhoea, sweating and depression.

  • The doctor should plan the taper before treatment begins.

  • Outside epilepsy, treatment should be as short as possible.

  • Children and adolescents under 18: not established, no dose given.

  • Elderly: a lower dose may be needed because of kidney function.

  • Liver impairment: no dose adjustment needed.

  • Take it with or without food.

HOW TO TAKE IT

  • Take it only on a doctor’s prescription.

  • Swallow the capsule whole with water.

  • Do not open, chew or crush the capsule.

  • It can be taken with or without food.

  • Take it at the same times every day.

  • Space two daily doses about 12 hours apart.

  • Space three daily doses about 8 hours apart.

  • Keep taking it even once symptoms improve.

  • Expect days to weeks before the full effect.

Do not confuse Lyrica with Lyrica CR

PointLyrica capsulesLyrica CR tablets
FormHard capsule, immediate releaseExtended-release tablet
StrengthsIncludes 300 mg82.5, 165 and 330 mg
FrequencyTwo or three times dailyOnce daily
TimingWith or without foodAfter an evening meal
Approved for fibromyalgiaYes, in the United StatesNo, efficacy not established
Approved as add-on for partial seizuresYesNo, efficacy not established
If creatinine clearance is under 30 mL/minUsed at reduced dosesNot recommended; patients receive immediate release
  • The two are not the same product and are not swapped freely.

  • Lyrica CR must be swallowed whole and never split or crushed.

  • Lyrica CR exposure falls about 30% if taken fasting.

  • Keep separate product pages for the two forms.

  • Dizziness, drowsiness and headache are very common at the start.

  • They usually settle as the body adjusts.

  • Do not drive until you know how it affects you.

  • Do not operate complex machinery.

  • Get up slowly from sitting or lying.

  • Falls have been reported, especially in older people.

What must never happen

  • Never drink alcohol with it; the effects add up.

  • Never combine it with an opioid without prescriber contact.

  • Never combine it with sedatives without medical advice.

  • Never raise your own dose.

  • Never stop it suddenly.

  • Never share your capsules with anyone else.

PRECAUTIONS

Absolute contraindications

  • Hypersensitivity to pregabalin or any excipient.

  • Stop it immediately if the face, mouth or airway swells.

  • Stop it immediately if a severe skin reaction develops.

  • Avoid it in rare hereditary galactose intolerance.

  • Avoid it in total lactase deficiency.

  • Avoid it in glucose-galactose malabsorption.

Conditions to disclose to your doctor

  • Any kidney disease, or dialysis.

  • Congestive heart failure or any cardiovascular compromise.

  • Any lung disease or neurological disease affecting breathing.

  • Sleep apnoea or any breathing problem during sleep.

  • Current treatment with opioid painkillers.

  • Current treatment with benzodiazepines or sleeping tablets.

  • Any history of drug or alcohol misuse.

  • Any history of depression or suicidal thoughts.

  • Diabetes, since weight gain may need a treatment change.

  • Any eye disease or previous vision loss.

  • Constipation, or treatment with opioids causing it.

  • Spinal cord injury, or treatment with anti-spasticity drugs.

  • Pregnancy, planned pregnancy or breastfeeding.

  • Older age, which raises the falls and breathing risk.

Pregnancy, stated plainly

  • Lyrica should not be used in pregnancy unless clearly necessary.

  • Women able to become pregnant must use effective contraception.

  • A Nordic study looked at over 2,700 first-trimester exposures.

  • Major congenital malformations occurred in 5.9% of exposed pregnancies.

  • The unexposed comparison figure was 4.1%.

  • The adjusted prevalence ratio was 1.14, range 0.96 to 1.35.

  • That result was not statistically significant.

  • Numbers for individual malformation types were small and imprecise.

  • Pregabalin passes into breast milk; the infant effect is unknown.

  • The doctor decides between stopping breastfeeding or the drug.

Food, drink and lifestyle precautions

  • No food restrictions; take it with or without food.

  • Avoid alcohol completely; pregabalin potentiates its effects.

  • Do not use recreational sedatives with it.

  • Weigh yourself regularly; weight increase is common.

  • Watch for swelling of the ankles and feet.

  • Diabetic patients should monitor blood sugar if weight rises.

  • Keep up gentle activity to limit weight gain.

  • Eat enough fibre and fluid; constipation is common.

  • Do not drive until you know the effect on you.

  • Tell every doctor and dentist that you take it.

Before-use safety checklist

  • Do you have a prescription from a registered practitioner?

  • Has the cause of your symptoms been diagnosed?

  • Has your kidney function been measured?

  • Is your creatinine clearance 60 mL/min or more?

  • Have you already been titrated up through lower strengths?

  • Is the intended daily dose within the cap for your condition?

  • Are you taking any opioid or sedative medicine?

  • Do you have any lung or breathing condition?

  • Could you be pregnant, and are you using contraception?

  • Do you have any problem with lactose or galactose?

  • Has an exit strategy and taper plan been discussed?

  • Do you know which symptoms need emergency care?

SIDE EFFECTS

About 12% of patients stopped treatment because of side effects, compared with 5% on placebo.

Very common and common side effects

Frequency bandEffects
Very common, 10% or moreDizziness, drowsiness, headache
Common, 1% to 10%, nervous systemAtaxia, tremor, memory impairment, pins and needles, vertigo
Common, mood and behaviourEuphoric mood, confusion, irritability, insomnia, reduced libido
Common, eyesBlurred vision, double vision
Common, digestiveNausea, vomiting, constipation, dry mouth, wind
Common, generalPeripheral oedema, fatigue, abnormal gait, falls, weight increase
Common, otherIncreased appetite, erectile dysfunction, nasopharyngitis

Uncommon side effects (1 in 1,000 to 1 in 100)

SystemEffects
BloodLow neutrophil count
MetabolicLow blood sugar, loss of appetite
ImmuneHypersensitivity
PsychiatricHallucinations, depression
Nervous systemFainting
Heart and circulationFast heartbeat, low blood pressure, high blood pressure, heart failure
RespiratoryBreathlessness
SkinRash, hives, excessive sweating
LiverRaised liver enzymes
UrinaryUrinary incontinence

Rare and very rare side effects

Frequency bandEffects
Rare, 1 in 10,000 to 1 in 1,000Angioedema, allergic reaction, suicidal ideation and behaviour
Rare, continuedDisinhibition, convulsions, QT prolongation, pancreatitis
Rare, continuedJaundice, renal failure, rhabdomyolysis, vision loss
Rare, skinStevens-Johnson syndrome and toxic epidermal necrolysis
Very rare, under 1 in 10,000Hepatitis, liver failure
Frequency not knownDrug dependence, respiratory depression

Withdrawal symptoms

  • Insomnia, headache, nausea and anxiety.

  • Diarrhoea, nervousness and depression.

  • Suicidal ideation, pain, sweating and dizziness.

  • Convulsions, which can occur without a history of epilepsy.

  • These are the reason the taper must be gradual.

  • Reported effects include drowsiness and confusion.

  • Also agitation and restlessness.

  • Seizures have been reported.

  • Coma has occurred rarely.

  • Treatment is supportive and may include haemodialysis.

DRUG INTERACTIONS – AVOID WITH

The dangerous combinations

Medicine groupEffectInstruction
Opioid painkillersRespiratory failure, coma and deaths reported after marketingAvoid unless the prescriber has judged it necessary
Oxycodone specificallyAdditive impairment of thinking and movementAvoid; no change in blood levels but effects add
Benzodiazepines and lorazepamPregabalin may potentiate the effectAvoid
Sleeping tabletsAdded sedation and breathing depressionAvoid
AlcoholPregabalin may potentiate the effectAvoid completely

Opioid-related death risk was higher with concomitant pregabalin, with an adjusted odds ratio of 1.68 and a range of 1.19 to 2.36. The trend pointed to greater risk above 300 mg a day.

Bowel and other effects

CombinationEffect
Opioids plus pregabalinConstipation, paralytic ileus and intestinal obstruction reported
Anti-spasticity drugs in spinal cord injuryAdditive drowsiness
Thiazolidinediones such as pioglitazoneMore oedema and weight gain
ACE inhibitorsBoth can cause angioedema; risk may add

Interactions that do not occur

  • No clinically relevant interaction with phenytoin.

  • No clinically relevant interaction with carbamazepine.

  • No clinically relevant interaction with valproic acid.

  • No clinically relevant interaction with lamotrigine.

  • No clinically relevant interaction with gabapentin.

  • Oral contraceptives are not affected at steady state.

  • Pregabalin is barely metabolised, so enzyme effects are unlikely.

  • Its risks come from added sedation, not from changed levels.

What to tell your pharmacist

  • List every painkiller, including any opioid.

  • List every sleeping or anti-anxiety tablet.

  • List every diabetes tablet.

  • List every blood pressure tablet.

  • Mention any lung condition or sleep apnoea.

  • Mention how much alcohol you drink, honestly.

EMERGENCY WARNING SIGNS

Get emergency medical help for any of these.

Signs of angioedema or a severe reaction

  • Swelling of the face, lips, gums, tongue or throat.

  • Swelling around the mouth or in the upper airway.

  • Difficulty breathing or swallowing.

  • Wheezing or a tight chest.

  • Widespread blistering, peeling skin or mouth sores.

  • A spreading rash with fever and feeling very unwell.

  • Very slow or shallow breathing.

  • Long pauses in breathing, especially during sleep.

  • Being hard to wake, or unresponsive.

  • Blue or grey lips or fingertips.

  • Severe confusion with heavy drowsiness.

Mental health warning signs

  • New or worsening thoughts of self-harm or suicide.

  • New or worsening depression.

  • Sudden agitation, irritability or aggression.

  • Hallucinations or loss of touch with reality.

  • These need medical attention the same day.

  • A seizure, especially after a missed or stopped dose.

  • Loss of consciousness or sudden severe confusion.

  • Unexplained muscle pain, tenderness or weakness.

  • Dark or cola-coloured urine with muscle pain.

  • Severe upper abdominal pain radiating to the back.

  • Yellowing of the eyes or skin.

  • Passing much less urine than usual.

  • Rapid leg swelling with breathlessness.

  • Sudden loss or blurring of vision.

  • Severe constipation with vomiting and a swollen abdomen.

  • Contact a doctor or poisons service immediately.

  • Take the pack so the dose is known.

  • Do not wait for symptoms to appear.

WHY CHOOSE THIS MEDICINE

Points in its favour

  • Lyrica is the original, reference brand of pregabalin.
  • Pregabalin is a first-line option for several nerve pain conditions.
  • Ordinary painkillers often do not help nerve pain at all.
  • In Europe it covers both peripheral and central neuropathic pain.
  • It is also approved there for generalised anxiety disorder.
  • It is approved as add-on treatment for partial seizures.
  • It is barely metabolised, so enzyme interactions are few.
  • No dose change is needed in liver impairment.
  • It is taken two or three times a day, not more often.
  • The 300 mg capsule lets a patient reach the maximum dose simply.
  • Shelf life is three years and no special storage is needed.

Points to be honest about

  • Dizziness, drowsiness and headache are very common.
  • About 12% of patients stop because of side effects.
  • Weight gain and ankle swelling are common.
  • It can cause dependence at normal therapeutic doses.
  • Coming off 600 mg a day needs at least three weeks.
  • It is misused, which is why India tightened its control.
  • This strength needs full kidney function.
  • Generic pregabalin contains the same molecule at lower cost.

What should never be claimed

  • Do not describe it as a general painkiller.
  • Do not describe it as non-habit-forming.
  • Do not describe it as a sleep aid or relaxant.
  • Do not describe it as safe to combine with opioids.
  • Do not promote it for anxiety outside a prescription context.
  • Do not claim the brand works better than a generic.

STORAGE INSTRUCTIONS

  • Keep the capsules in the original blister or bottle.
  • Protect them from moisture and from light.
  • Do not store them in a bathroom cabinet.
  • Do not transfer them into an unlabelled container.
  • Keep them out of the sight and reach of children.
  • Do not use after the expiry date on the pack.
  • Return unused or expired capsules to a pharmacy.
  • Do not keep leftover capsules for a future episode.
  • Do not pass unused capsules to anyone else.
  1. Keep retail stock in a secure, controlled location.
  2. Reconcile stock against the Schedule H1 register regularly.
  3. Investigate any discrepancy promptly.
  4. Keep the register and prescription copies for three years.
  5. Dispose of expired stock through a documented route.

Sanjay Gangani

Sanjay Gangani

B.Pharm, CMO & Pharmacist

Licensed pharmacist (B.Pharm) with 12+ years in clinical pharmacy and patient care. Reviews every article for evidence-based accuracy before it is published on ACTIZA Store.

Reviews

There are no reviews yet.

Be the first to review “Lyrica 300 mg (Generic)”

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

All Categories

Shopping Cart

0
×

Loading cart...